Accessibility: Skip TopNav
4D-150 clinical efficacy endpoints for evaluable patients in all three cohorts (n=14) at 36 weeks
Table for 4D-150 clinical efficacy endpoints for evaluable patients in all three cohorts (n=14) at 36 weeks
Format
JPEG
Source
4D Molecular Therapeutics, Inc.
Downloads
Original
Large
Medium
Small